BioSpace News Archive

LifePod® Solutions, the first proactive-voice caregiving service, today announced Dr. John Loughnane’s appointment as Chief Medical Advisor.

Rosalind Franklin University of Medicine and Science announced a research collaboration with the Chicagoland biotech company Exicure Inc. to develop new therapeutics for genetic diseases.

Donation of ￥2.1 million ($300,000) in cash and doTERRA products to benefit front-line medical staff and Shanghai-area hospitals, including Shanghai Children’s Medical Center

Feb. 13, 2020 15:56 UTC Co-Diagnostics Announces Closing of $10.2 Million Registered Direct Offering Priced At-the-Market SALT LAKE CITY--( BUSINESS WIRE )-- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced registered direct offering of 3,324,676 shares of its common stock at a purchase price per share of $3.08 in a registe

BioMatrix Specialty Pharmacy announced today they have been named one of the Best and Brightest Companies to Work For® by the National Association for Business Resources (NABR)

Retrophin, Inc. announced that on February 10, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 22,500 shares of its common stock to three new employees and granted inducement restricted stock units, or RSUs, covering an aggregate of 8,000 shares of its common stock to seven new employees.

Phio Pharmaceuticals Corp. announced the closing of its previously announced underwritten public offering of 993,633 units at a public price of $4.00 per unit and 1,006,367 pre-funded units at a public price of $3.999 per pre-funded unit, raising gross proceeds of approximately $8.0 million, prior to deducting underwriting discounts and commissions and estimated offering expenses.

A tiny molecule of RNA – known as ‘micro RNA’ – plays a key role in ‘rewiring’ cancer cells so they can resist the effects of chemotherapy, a new study reveals.

International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces that it is hosting a symposium to drive the debate: Are Randomized Clinical Trials Obsolete?

Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as Chief Technology Officer, VP of Formulation R&D and Product Development.